Coldstream Capital Management Inc Inmune Bio, Inc. Call Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INMB
# of Institutions
89Shares Held
6.93MCall Options Held
240KPut Options Held
74.6K-
Vanguard Group Inc Valley Forge, PA827KShares$6.03 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$5.93 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR812KShares$5.93 Million1.52% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$4.35 Million45.87% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL382KShares$2.79 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $131M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...